LYTTON LAURENCE W 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-15 1:09 pm Sale |
2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 85,416 2.500% |
-81,604 (-48.86%) |
Filing |
| 2021-03-05 7:26 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 167,020 7.000% |
30,666 (+22.49%) |
Filing |
| 2021-03-05 4:55 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 136,354 5.700% |
136,354 (New Position) |
Filing |